(Q39989304)

16 September 2017

title

Effects of growth hormone release-inhibiting hormone and bromocryptine (CB 154) in states of abnormal pituitary-adrenal function (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A178470

23 December 2022

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1976.TB02831.X

23 December 2022

author name string

G. Benker

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A178470

23 December 2022

K. Hackenberg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A178470

23 December 2022

B. Hamburger

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A178470

23 December 2022

D. Reinwein

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A178470

23 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=178470

23 December 2022

publication date

1 March 1976

1 reference

full work available at URL

16 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2265.1976.tb02831.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1976.TB02831.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2265.1976.tb02831.x/fullpdf

23 December 2022

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1976.TB02831.X

23 December 2022

published in

Clinical Endocrinology

1 reference

16 September 2017

volume

5

1 reference

16 September 2017

issue

2

1 reference

16 September 2017

page(s)

187-190

1 reference

Action of growth-hormone-release inhibitory hormone in healthy men and in acromegaly.

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1976.TB02831.X

Growth hormone release inhibiting hormone in acromegaly

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1976.TB02831.X

Cyproheptadine-Induced Remission of Cushing's Disease

23 December 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1976.TB02831.X

Growth hormone (GH)-releasing activity of TRH and GH-lowering effect of dopaminergic drugs in acromegaly: homogeneity in the two responses

23 December 2022

6

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1976.TB02831.X

A radioimmunoassay for rat plasma ACTH.

23 December 2022

8

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1976.TB02831.X

Bromocriptine treatment of acromegaly

23 December 2022

9

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1976.TB02831.X

Inhibition by somatostatin of ACTH secretion in Nelson's syndrome

23 December 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1976.TB02831.X

23 December 2022

Identifiers

1 reference

16 September 2017

1 reference